arrow
Back
A

Angus Dalgleish

city st georges, university of london

69H-index
555Paper Count
2.4WCitation Count
Published Papers 86
Publication Date
errShare
errSave
Co-expression and prognostic significance of HER family members and EGFRvIII in patients with hepatocellular carcinoma
err2024-03-22
err0
PREAI
errSherif, Ozlem; Khelwatty, Said; Bagwan, Izhar; Seddon, Alan; Dalgleish, Angus; Mudan, Satvinder; Modjtahedi, Helmout
errShare
errSave
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance
err2023-01-13
err3
errOAAI
errRidgley, Laura A.; Caron, Jonathan; Dalgleish, Angus; Bodman-Smith, Mark
errShare
errSave
Editorial: Immunotherapy for Prostate Cancer - turning the immunological desert into an oasis of hope
err2022-09-08
err3
errOAAI
errGalustian, Christine; Dalgleish, Angus; Bodman-Smith, Mark; Kusmartsev, Sergei; Dasgupta, Prokar
errShare
errSave
Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acid
err2022-04-11
err6
errOAAI
errFenn, J.; Ridgley, L. A.; White, A.; Sarfas, C.; Dennis, M.; Dalgleish, A.; Reljic, R.; Sharpe, S.; Bodman-Smith, M.
errShare
errSave
Combination of cannabidiol with low-dose naltrexone increases the anticancer action of chemotherapy in vitro and in vivo
err2022-02-18
err2
errOAAI
errLiu, Wai M.; Hall, Nadine K.; Liu, Harry S. Y.; Hood, Francis L.; Dalgleish, Angus G.
errShare
errSave
Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2
err2022-01-21
err3
errOAAI
errPiadel, Katarzyna; Haybatollahi, Amin; Dalgleish, Angus George; Smith, Peter Lawrence
errShare
errSave
Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy
err2021-11-25
err10
errOAAI
errSmith, Peter Lawrence; Piadel, Katarzyna; Dalgleish, Angus George
errShare
errSave
The immuno-oncological implications of insulin
err2021-01-01
err7
errOAAI
errvan Niekerk, Gustav; Dalgleish, Angus G.; Joubert, Fourie; Joubert, Annie; Engelbrecht, Anna-Mart
errShare
errSave
RELEASING THE RESTRAINTS OF Vγ9Vδ2 T-CELLS IN CANCER IMMUNOTHERAPY
err2020-11-09
err0
errOAAI
errRidgley, Laura; Dalgleish, Angus; Bodman-Smith, Mark
errShare
errSave
errShare
errSave
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma
err2020-04-20
err25
errOAAI
errCebon, Jonathan S.; Gore, Martin; Thompson, John F.; Davis, Ian D.; McArthur, Grant A.; Walpole, Euan; Smithers, Mark; Cerundolo, Vincenzo; Dunbar, P. Rod; MacGregor, Duncan; Fisher, Cyril; Millward, Michael; Nathan, Paul; Findlay, Michael P. N.; Hersey, Peter; Evans, T. R. Jeffry; Ottensmeier, Christian Hermann; Marsden, Jeremy; Dalgleish, Angus G.; Corrie, Pippa G.; Maria, Marples; Brimble, Margaret; Williams, Geoff; Winkler, Sintia; Jackson, Heather M.; Endo-Munoz, Liliana; Tutuka, Candani S. A.; Venhaus, Ralph; Old, Lloyd J.; Haack, Dennis; Maraskovsky, Eugene; Behren, Andreas; Chen, Weisan
errShare
errSave
Mycobacterial immunotherapy for prostate cancer: where can we go from here?
err2020-01-29
err2
errOAAI
errStavrinides, Vasilis; Dalgleish, Angus; Copier, John P.; Moore, Caroline M.
errShare
errSave
Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer
err2020-01-17
err3
errOAAI
errArias-Pinilla, Gustavo A.; Dalgleish, Angus G.; Mudan, Satvinder; Bagwan, Izhar; Walker, Anthony J.; Modjtahedi, Helmout
errShare
errSave
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial (vol 29, pg 1843, 2018)
err2019-12-01
err4
errOAAI
errCorrie, P. G.; Marshall, A.; Nathan, P. D.; Lorigan, P.; Gore, M.; Tahir, S.; Faust, G.; Kelly, C. G.; Marples, M.; Danson, S. J.; Marshall, E.; Houston, S. J.; Board, R. E.; Waterston, A. M.; Nobes, J. P.; Harries, M.; Kumar, S.; Goodman, A.; Dalgleish, A.; Martin-Clavijo, A.; Westwell, S.; Casasola, R.; Chao, D.; Maraveyas, A.; Patel, P. M.; Ottensmeier, C. H.; Farrugia, D.; Humphreys, A.; Eccles, B.; Young, G.; Barker, E. O.; Harman, C.; Weiss, M.; Myers, K. A.; Chhabra, A.; Rodwell, S. H.; Dunn, J. A.; Middleton, M. R.
errShare
errSave
The successful treatment of metastatic androgen receptor-positive tumours of parotid origin with androgen receptor blockade and immunotherapy
err2019-05-01
err1
errOAAI
errDalgleish, Angus G.; Di Palma, Silvana; Nathan, Kannon; Powell, Barry; Patel, Nirav; Fusi, Alberto
errShare
errSave
errShare
errSave
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
err2018-08-01
err52
errOAAI
errCorrie, P. G.; Marshall, A.; Nathan, P. D.; Lorigan, P.; Gore, M.; Tahir, S.; Faust, G.; Kelly, C. G.; Marples, M.; Danson, S. J.; Marshall, E.; Houston, S. J.; Board, R. E.; Waterston, A. M.; Nobes, J. P.; Harries, M.; Kumar, S.; Goodman, A.; Dalgleish, A.; Martin-Clavijo, A.; Westwell, S.; Casasola, R.; Chao, D.; Maraveyas, A.; Patel, P. M.; Ottensmeier, C. H.; Farrugia, D.; Humphreys, A.; Eccles, B.; Young, G.; Barker, E. O.; Harman, C.; Weiss, M.; Myers, K. A.; Chhabra, A.; Rodwell, S. H.; Dunn, J. A.; Middleton, M. R.
errShare
errSave